Skip to navigation Skip to search Skip to main content Skip to footer
Foreign Policy Magazine Foreign Policy Magazine
  • Sign In
  • Give a Gift Give a Gift
  • Subscribe Subscribe Upgrade Upgrade
  • Sign In
  • Latest
  • News
  • Analysis
  • Podcasts
  • The Magazine
  • Newsletters
  • FP Live
  • Events
  • FP Analytics
Search Icon

latest

Zelensky Pleads With Washington for More War Aid

But right-wing pushback could kill Ukraine’s weapons wish list before it leaves the U.S. Congress’s floor.

World Brief

|

Alexandra Sharp

Meet Ukraine’s New Defense Boss

He’s not the same as the old boss.

Situation Report

|

Jack Detsch, Amy Mackinnon

Can the U.S. and China Cooperate on Green Technology Again?

A recent book makes the case for collaboration in an increasingly competitive industry.

Review

|

Lili Pike

Can India and Pakistan’s Historic Water Pact Endure?

The Indus Waters Treaty was created to avoid conflict. To confront the climate crisis, it must evolve.

Analysis

|

Betsy Joles
See All Stories
  • FP Events
  • FP Studios
  • FP Analytics
  • FP PeaceGames
  • Subscription Services
  • Group Subscriptions
  • Reprint Permissions
  • Writer’s Guidelines
  • FP Guides – Graduate Education
  • FP For Education
  • FP Archive
  • Buy Back Issues
  • Work At FP
  • Meet the Staff
  • Advertising/Partnerships
  • Country Reports
  • Sign In
  • Give a Gift Give a Gift
  • Subscribe Subscribe Upgrade Upgrade
  • Sign In
Search Icon

: Takeda breathes new life into drug development

  • Email
  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Reddit
Sponsored Content
Japan and the US: The Bigger Picture

Takeda breathes new life into drug development

Scientists working at TRI-I TDI
Scientists working at TRI-I TDI

Two Takeda scientists

 

$2.6 billion. That’s what it costs to develop a single drug. Most pharmaceutical companies take on projects where there is little risk, a lot of validation and a huge market appetite. This means that a lot of good ideas and research never make it into the marketplace and fall into an abyss known as “the valley of death.”

Takeda Pharmaceuticals, however, chose to do something different. The company relocated 15 of its scientists to the U.S. from Japan to work with researchers at Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College, forming a new partnership known as the Tri-Institutional Therapeutics Discovery Institute (TDI).

TDI doesn’t even entertain a conversation about a drug’s profitability or market size. Takeda, which is Japan’s largest pharmaceutical company, and the research centers are more concerned with answering a fundamental question about how disease works and bringing research to the proof-of-concept stage where drug companies might invest in them. Projects are chosen after an in-depth review by a professional scientific advisory board and are picked based on whether the institute thinks it can help develop a high quality compound or antibody to better work with the disease.

“We were looking for access to novel biology, which is what academics do really, really well, especially these institutions, which are world renowned,” says Juan Harrison, a vice president in Takeda Pharmaceuticals Inter- national’s new frontier science division. The partnership allows Takeda to witness cutting-edge science first-hand, and pass along valuable information about drug discovery and design.

Dr. Carl Nathan
Dr. Carl Nathan

Dr. Carl Nathan is chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine and a TDI board member.

“I’ve been a proponent of open labs for years,” says Dr. Carl Nathan, who is chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine and a TDI board member. “Putting everyone near each other matters a lot,” says Nathan.“They talk to each other, exchange ideas and learn from each other. It’s way faster, way cheaper, and a lot more fun than the old way.”

Other Stories in Japan and the US: The Bigger Picture

  • Japan and the US: The Bigger Picture — Home
  • Partners in Prosperity
  • Investing in the US and its Communities
  • Supporting U.S. Economic Growth
  • Japanese Notebook Turns the Page for Infant Health
  • Akie Abe Speaks Her Own Mind to Give Women A Voice
  • The Results Are In—Womenomics Is Working
  • FP’s U.S. Japan Forum 2016
  • Nothing but Net: Fighting the Scourge of Malaria
  • Japan’s Contribution to a More Vibrant Africa
  • Japan’s Commitment to Development in Africa
  • Japan Is a Technology and Innovation Leader
  • Fujifilm captures hope in Ebola fight
  • Combating Climate Change: A Global Commitment
  • Creating Greener Communities in the U.S.
  • Supercharging the U.S. Power Supply

Watch the FP Japan Event

See the replay of FP's recent event in Washington, D.C. on the future of the US-Japan relationship here.

Connect with Japan

  • Check out FP's U.S.-Japan Forum 2016
  • on Twitter
  • on Facebook
  • on Instagram
  • We are Tomodachi
  • Highlighting Japan Magazine
  • Japan Public Relations Office
  • Japan-Related Events in Washington, DC

Political & Economic Resources

  • Government of Japan
  • The JapanGov App:
    • on the App Store
    • on Google Play
    • on Amazon
  • Embassy of Japan in the US
  • JapanGov Weekly
  • Prime Minister and His Cabinet
  • Japan External Trade Organization (JETRO)
  • Japan International Cooperation Agency (JICA)

Cultural Resources

  • Japan Information and Culture Center (JICC)
  • Nipponica Magazine
  • Japan National Tourism Organization (JNTO)
  • Visit Japan
  • Japan Exchange and Teaching Program (JET)

Japan and the US: The Bigger Picture is a series of sponsored reports and articles studying the long-standing alliance between Japan and the United States with a focus on unique economic and political success stories. It is underwritten by the Embassy of Japan and produced by an independent writer in conjunction with the business department of The FP Group.

Japan and the US: The Bigger Picture does not involve the editorial staff of Foreign Policy magazine or ForeignPolicy.com.

For any questions or comments, please contact Duc Luu, Director, International, at duc.luu@foreignpolicy.com.

Loading graphics
Foreign Policy Magazine
Foreign Policy Magazine
  • FP Events
  • FP Studios
  • FP Analytics
  • FP PeaceGames
  • Subscription Services
  • Group Subscriptions
  • Reprint Permissions
  • Writer’s Guidelines
  • FP Guides – Graduate Education
  • FP For Education
  • FP Archive
  • Buy Back Issues
  • Work At FP
  • Meet the Staff
  • Advertising/Partnerships
  • Country Reports
  • Contact Us
  • Privacy Policy
Powered by WordPress VIP
© 2023, Graham Digital Holding Company